Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 249Rectal Neoplasms 154Pancreatic Neoplasms 125Stomach Neoplasms 105Colonic Neoplasms 104Esophageal Neoplasms 90Neoplasm Metastasis 69Breast Neoplasms 61Squamous Cell Carcinoma of Head and Neck 47Carcinoma, Hepatocellular 42Adenocarcinoma Of Esophagus 41Head and Neck Neoplasms 39Esophageal Squamous Cell Carcinoma 38Neoplasms 37Nasopharyngeal Carcinoma 30Adenocarcinoma 24Cholangiocarcinoma 20Keratosis, Actinic 17Carcinoma, Squamous Cell 16Biliary Tract Neoplasms 16Liver Neoplasms 15Gastrointestinal Neoplasms 15Anus Neoplasms 14Gallbladder Neoplasms 11Bile Duct Neoplasms 11Peritoneal Neoplasms 10Laryngeal Neoplasms 9Recurrence 8Nasopharyngeal Neoplasms 7Colorectal Cancer Metastatic 7

Interventions

methyl 5-aminolevulinate 2Tomography, Optical Coherence 1Photochemotherapy 1Myelin and Lymphocyte-Associated Proteolipid Proteins 1Microphysiological Systems 1Lidocaine, Prilocaine Drug Combination 1Lidocaine 1Laser Therapy 1Fluorouracil 1Epinephrine 1Cryotherapy 1Anesthesia, Local 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Bowen's Disease × Fluorouracil × Clear all
NCT03909646 2025-05-06

BOWTIE

Maastricht University Medical Center

Phase 4 Completed
250 enrolled

Bowen's Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡